IRIDEX Corporation

IRIX

US4626841013

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-28 EDT			5-day change	1st Jan Change
2.47 ^USD	+0.82%		-8.18%	-12.10%

05-24	IRIDEX Corporation Appoints Patrick Mercer as Its President	CI
05-14	Transcript : IRIDEX Corporation, Q1 2024 Earnings Call, May 14, 2024

IRIDEX Corporation Elects Nandini Devi as a Director of the Company

June 21, 2021 at 04:16 pm

IRIDEX Corporation announced that at its AGM held on June 16, 2021, it has approved the election of Nandini Devi as a director of the company.

Latest news about IRIDEX Corporation

IRIDEX Corporation Appoints Patrick Mercer as Its President	05-24	CI
Transcript : IRIDEX Corporation, Q1 2024 Earnings Call, May 14, 2024	05-14
Earnings Flash (IRIX) IRIDEX CORPORATION Posts Q1 Revenue $11.8M, vs. Street Est of $12M	05-14	MT
Transcript : IRIDEX Corporation, Q4 2023 Earnings Call, Mar 26, 2024	03-26
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $12.5M, vs. Street Est of $14.9M	03-26	MT
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-26	CI
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter Ended December 30, 2023	03-26	CI
North American Morning Briefing : Markets Steady -2-	03-26	DJ
Iridex Corporation Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust	01-24	CI
Iridex Corporation Launches New Iridex 532 and Iridex 577 Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma	01-11	CI
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation	11-27	CI
Transcript : IRIDEX Corporation, Q3 2023 Earnings Call, Nov 14, 2023	11-14
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q3 Revenue $12.9M, vs. Street Est of $13.5M	11-14	MT
IRIDEX Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
IRIDEX Corporation Withdraws Previously Announced Guidance for 2023	11-14	CI
Wall Street Set to Open Mixed Ahead of Federal Reserve Meeting	11-01	MT
IRIDEX Hires Advisers to Explore Strategic Alternatives	23-08-29	MT
Iridex Announces Strategic Review to Unlock Shareholder Value	23-08-29	CI
Transcript : IRIDEX Corporation, Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
IRIDEX Corporation Reports Earnings Results for the Second Quarter and Six Months Ended July 01, 2023	23-08-10	CI
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q2 Revenue $12.9M, vs. Street Est of $14.2M	23-08-10	MT
IRIDEX Corporation Provides Revenue Guidance for the Year 2023	23-08-10	CI
IRIDEX Corporation(NasdaqGM:IRIX) dropped from Russell Microcap Value Index	23-06-23	CI
IRIDEX Corporation(NasdaqGM:IRIX) dropped from Russell 3000E Value Index	23-06-23	CI
Transcript : IRIDEX Corporation, Q1 2023 Earnings Call, May 11, 2023	23-05-11

IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-18 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for IRIDEX Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.47 USD

Average target price

2 USD

Spread / Average Target

-19.03%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
IRIDEX CORPORATION	-12.10%	40.14M
THERMO FISHER SCIENTIFIC	+7.87%	219B
DANAHER CORPORATION	+11.83%	192B
INTUITIVE SURGICAL, INC.	+18.87%	142B
BOSTON SCIENTIFIC CORPORATION	+30.03%	111B
SIEMENS HEALTHINEERS AG	+2.32%	65.32B
EDWARDS LIFESCIENCES CORPORATION	+14.15%	52.45B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.68%	49.8B
AGILENT TECHNOLOGIES, INC.	+6.60%	43.43B
GE HEALTHCARE TECHNOLOGIES INC.	+1.85%	35.95B

Other Advanced Medical Equipment & Technology